Dietary phosphorus intake and mortality in moderate chronic kidney disease: NHANES III

Nephrology Dialysis Transplantation

Volumn 27, Issue 3, 2012, Pages 990-996

  Murtaugh, Maureen A ^a   Filipowicz, Rebecca ^a   Baird, Bradley C ^a   Wei, Guo ^a   Greene, Tom ^a   Beddhu, Srinivasan ^a,b  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^b Renal Section VA Healthcare System   (United States)

Author keywords

Dietary phosphorus intake; Moderate chronic kidney disease; Mortality

Indexed keywords

PHOSPHORUS;

ADULT; AGED; ARTICLE; CALORIC INTAKE; CHRONIC KIDNEY DISEASE; COMORBIDITY; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DISEASE SEVERITY; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; NUTRITIONAL ASSESSMENT; NUTRITIONAL STATUS; PATIENT ASSESSMENT; PHOSPHATE BLOOD LEVEL; PHOSPHATE INTAKE; PHOSPHATE METABOLISM; PHYSICAL ACTIVITY; PRIORITY JOURNAL; QUALITY OF LIFE;

EID: 84861135078     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfr367     Document Type: Article

References (43)

1. Kestenbaum B. Phosphate metabolism in the setting of chronic kidney disease: significance and recommendations for treatment. Semin Dial 2007; 20: 286-294
2. Chertow GM, Raggi P, Chasan-Taber S et al. Determinants of progressive vascular calcification in haemodialysis patients. Nephrol Dial Transplant 2004; 19: 1489-1496
3. Ganesh SK, Stack AG, LevinNWet al. Association of elevated serum PO(4), Ca x PO(4) product, and parathyroid hormone with cardiac mortality risk in chronic hemodialysis patients. J Am Soc Nephrol 2001; 12: 2131-2138
4. Kalantar-Zadeh K, Kuwae N, Regidor DL et al. Survival predictability of time-varying indicators of bone disease in maintenance hemodialysis patients. Kidney Int 2006; 70: 771-780
5. Block GA, Hulbert-Shearon TE, Levin NW et al. Association of serum phosphorus and calcium x phosphate product with mortality risk in chronic hemodialysis patients: a national study. Am J Kidney Dis 1998; 31: 607-617
6. Guerin AP, London GM, Marchais SJ et al. Arterial stiffening and vascular calcifications in end-stage renal disease. Nephrol Dial Transplant. 2000; 15: 1014-1021
7. Levin A, Bakris G, Molitch M et al. Prevalence of abnormal serum vitamin D, PTH, calcium, and phosphorus in patients with chronic kidney disease: results of the study to evaluate early kidney disease. Kidney Int 2007; 71: 31-38
8. Pires A, Adragão T,PaisMJet al. Inferring. disease mechanisms from epidemiological data in chronic kidney disease: calcium and phosphorus metabolism. Nephron Clin Pract 2009; 112: c137-c147
9. Eddington H, Hoefield R, Sinha S et al. Serum phosphate and mortality in patients with chronic kidney disease. Clin J Am Soc Nephrol 2010; 5: 2251-2257
10. Kovesdy CP, Anderson JE, Kalantar-Zadeh K. Outcomes associated with serum phosphorus level in males with non-dialysis dependent chronic kidney disease. Clin Nephrol 2010; 73: 268-275
11. Hladky JP, Lejeune JP, Singer B et al. Osteoblastoma of the odontoid process. Pediatr Neurosurg 1994; 21: 260-262
12. Coresh J, Selvin E, Stevens LA et al. Prevalence of chronic kidney disease in the United States. JAMA 2007; 298: 2038-2047
13. Levey AS, Coresh J, Greene T et al. Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate. Ann InternMed 2006; 145: 247-254
14. Sun SS, Chumlea WC, Heymsfield SB et al. Development of bioelectrical impedance analysis prediction equations for body composition with the use of a multicomponent model for use in epidemiologic surveys. Am J Clin Nutr 2003; 77: 331-340
15. National Center for Health Statistics: The Third National Health and Nutrition Examination Survey (NHANES III). Linked Mortality File: Matching Methodology. 2005; http://www.cdc.gov/nchs/data/datalinkage/matching- methodology-nhanes3-final.pdf (3 March 2009, date last accessed)
16. National Center for Health Statistics. Analytical and Reporting guidelines: The Third National Health and Nutrition Examination Survey, 1988-1994. Hyattsville, MD, 1996 (24 April 2005, date last accessed)
17. Ix JH, De Boer IH, Peralta CA et al. Serum phosphorus concentrations and arterial stiffness among individuals with normal kidney function to moderate kidney disease in MESA. Clin J Am Soc Nephrol 2009; 4: 609-615
18. Dhingra R, Sullivan LM, Fox CS et al. Relations of serum phosphorus and calcium levels to the incidence of cardiovascular disease in the community. Arch Intern Med 2007; 167: 879-885
19. Foley RN, Collins AJ, Ishani A et al. Calcium-phosphate levels and cardiovascular disease in community-dwelling adults: the Atherosclerosis Risk in Communities (ARIC) Study. Am Heart J 2008; 156: 556-563
20. Gutierrez OM, Wolf M. Dietary phosphorus restriction in advanced chronic kidney disease: merits, challenges, and emerging strategies. Semin Dial 2010; 23: 401-406
21. Sigrist MK, Taal MW, Bungay P et al. Progressive vascular calcification over 2 years is associated with arterial stiffening and increased mortality in patients with stages 4 and 5 chronic kidney disease. Clin J Am Soc Nephrol 2007; 2: 1241-1248
22. Kovesdy CP, Kuchmak O, Lu JL et al. Outcomes associated with phosphorus binders in men with non-dialysis-dependent CKD. Am J Kidney Dis 2010; 56: 842-851
23. de Boer IH, Rue TC, Kestenbaum B. Serum phosphorus concentrations in the third National Health and Nutrition Examination Survey (NHANES III). Am J Kidney Dis 2009; 53: 399-407
24. Antoniucci DM, Yamashita T, Portale AA. Dietary phosphorus regulates serum fibroblast growth factor-23 concentrations in healthy men. J Clin Endocrinol Metab 2006; 91: 3144-3149
25. Yilmaz MI, Sonmez A, Saglam M et al. FGF-23 and vascular dysfunction in patients with stage 3 and 4 chronic kidney disease. Kidney Int 2010; 78: 679-685
26. Kanbay M, Nicoleta M, Selcoki Y et al. Fibroblast growth factor 23 and fetuin A are independent predictors for the coronary artery disease extent in mild chronic kidney disease. Clin J Am Soc Nephrol 2010; 5: 1780-1786
27. Gutierrez OM, Januzzi JL, Isakova T et al. Fibroblast growth factor 23 and left ventricular hypertrophy in chronic kidney disease. Circulation 2009; 119: 2545-2552
28. Gutierrez OM, Mannstadt M, Isakova T et al. Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis. N Engl J Med 2008; 359: 584-592
29. Shuto E, Taketani Y, Tanaka R et al. Dietary phosphorus acutely impairs endothelial function. J Am Soc Nephrol 2009; 20: 1504-1512
30. Kusano K, Segawa H, Ohnishi R et al. Role of low protein and low phosphorus diet in the progression of chronic kidney disease in uremic rats. J Nutr Sci Vitaminol 2008; 54: 237-243
31. Noori N, Kalantar-Zadeh K, Kovesdy CP et al. Association of dietary phosphorus intake and phosphorus to protein ratio with mortality in hemodialysis patients. Clin J Am Soc Nephrol 2010; 5: 683-692
32. Carroll RJ, Ruppert D, Stefanski LA et al. Measurement Error in Nonlinear Models: A Modern Perspective. 2nd edn. New York, NY: Chapman & Hall, 2006
33. Isakova T, Gutierrez OM, Chang Y et al. Phosphorus binders and survival on hemodialysis. J Am Soc Nephrol 2009; 20: 388-396
34. Russo D, Miranda I, Ruocco C et al. The progression of coronary artery calcification in predialysis patients on calcium carbonate or sevelamer. Kidney Int 2007; 72: 1255-1261
35. Isakova T, Gutierrez OM, Smith K et al. Pilot study of dietary phosphorus restriction and phosphorus binders to target fibroblast growth factor 23 in patients with chronic kidney disease. Nephrol Dial Transplant 2011; 26: 584-591
36. Shinaberger C, Greenland S, Kopple J et al. Is controlling phosphorus by decreasing dietary protein intake beneficial or harmful in persons with chronic kidney disease? Am J Clin Nutr 2008; 88: 1511
37. De Lorenzo A, Noce A, Bigioni M et al. The effects of Italian Mediterranean organic diet (IMOD) on health status. Curr Pharm Des 2010; 16: 814-824
38. Ahlenstiel T, Pape L, Ehrich JH et al. Self-adjustment of phosphate binder dose to meal phosphorus content improves management of hyperphosphataemia in children with chronic kidney disease. Nephrol Dial Transplant 2010; 25: 3241-3249
39. Rule AD, Larson TS, Bergstralh EJ et al. Using serum creatinine to estimate glomerular filtration rate: accuracy in good health and in chronic kidney disease. Ann Intern Med 2004; 141: 929-937
40. Benini O, D'Alessandro C, Gianfaldoni D et al. Extra-phosphate load from food additives in commonly eaten foods: a real and insidious danger for renal patients. J Ren Nutr 2010, doi:10.1053/ j.jrn.2010.06.021
41. Sullivan CM, Leon JB, Sehgal AR. Phosphorus-containing food additives and the accuracy of nutrient databases: implications for renal patients. J Ren Nutr 2007; 17: 350-354
42. Gutierrez OM, Isakova T, Enfield G et al. Impact of poverty on serum phosphate concentrations in the Third National Health and Nutrition Examination Survey. J Ren Nutr 2011; 21: 140-148
43. Gutierrez OM, Anderson C, Isakova T et al. Low socioeconomic status associates with higher serum phosphate irrespective of race. J Am Soc Nephrol 2010; 21: 1953-1960